THE IMMUNOLOGIC DOUBLET OF LENALIDOMIDE PLUS OBINUTUZUMAB...

Hematological Oncology 2017 / 06 Vol. 35

THE IMMUNOLOGIC DOUBLET OF LENALIDOMIDE PLUS OBINUTUZUMAB IS HIGHLY ACTIVE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA, RESULTS OF A PHASE I/II STUDY

Fowler, N.H., Samaniego, F., Turturro, F., Neelapu, S., Forbes, S., Westin, J., Fayad, L., Fanale, M., Feng, L., Arafat, J., Neal, E., Hagemeister, F., Nastoupil, L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_140
Date:
June, 2017
File:
PDF, 94 KB
english, 2017
Conversion to is in progress
Conversion to is failed